The nightly ledger

Stock catalysts from the latest SEC filings

Every 8-K, 10-Q and 10-K that AIR's companies filed on SEC EDGAR, and what each one changed in AIR's read. Material filings first, newest first — never ordered by price. For 8-K filing alerts, follow a company and turn on filing emails.

By event type: Acquisitions · Major contracts

Seven-day window, 2 weeks back · Material filings: 1629 · All filings: 1839

Material

Thursday 5 Nov642 filings read · 590 material

  • 10-QFiled 5 Nov 2026Biotech

    REGENXBIO Inc.RGNX

    Quarterly report (10-Q), period ending 30 Sep 2026

    Value: Weak 15 → Watch 43Gap High · 35 → High · 40

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Weak
    Material
  • 10-QFiled 5 Nov 2026All industries

    Graham CorpGHM

    Quarterly report (10-Q), period ending 30 Sep 2026

    Recognition: Balanced 48 → Balanced 52Value: Weak 18 → Watch 25Gap Very high · 49 → Very high · 54

    More of the market is starting to notice.

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Lantheus Holdings, Inc.LNTH

    8-K · Item 2.02 — Results of operations

    Q3 2026: Revenue $389.9M (+1.5% YoY), adjusted EPS $1.68 (+32.3% YoY). FDA approved TAUKLARIFY and BRAVNETSA. Pending $8B Curium merger at $102.50/share plus up to $12/share CVRs.

    Recognition: Balanced 55 → Balanced 50

    Market attention has faded.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    Cars.com Inc.CARS

    8-K · Item 2.02 — Results of operations

    Cars.com reported Q3 2026 net income up 113% YoY to $16.3M on flat revenue of $181.9M. Adjusted EBITDA margin of 30.7% exceeded guidance by 120 bps. Marketplace revenue grew 5% YoY; Premium+ adoption reached 12%. Company reaffirmed full-year guidance.

    Recognition: Balanced 55 → Balanced 62Gap Low · 0 → Low · 3

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 10-QFiled 5 Nov 2026Industrials

    Loar Holdings Inc.LOAR

    Quarterly report (10-Q), period ending 30 Sep 2026

    Recognition: Balanced 60 → Strong 66Gap Medium · 23 → High · 27

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 10-QFiled 5 Nov 2026Banks

    Ofg BancorpOFG

    Quarterly report (10-Q), period ending 30 Sep 2026

    Value: Watch 37 → Balanced 58

    The shares became cheaper on AIR's value read.

    The price trend weakened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Disc Medicine, Inc.IRON

    8-K · Item 2.02 — Results of operations

    Disc Medicine's Phase 3 APOLLO trial of bitopertin met all primary and secondary endpoints in erythropoietic protoporphyria. NDA resubmission planned by end-2026 with FDA decision anticipated mid-2027. Strong cash position of $683M extended to 2030.

    Gap High · 31 → High · 36

    Progress is running ahead of attention.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Rigel Pharmaceuticals IncRIGL

    8-K · Item 2.02 — Results of operations

    Q3 2026: $80.9M revenues (+13% YoY), $13.2M net income. VEPPANU launch generated $6.6M in initial sales. Full-year guidance raised to $290–295M. R289 Phase 1b ongoing; Phase 2 dose selection expected by end-2026.

    Recognition: Balanced 60 → Balanced 57Gap High · 27 → High · 38

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 10-QFiled 5 Nov 2026All industries

    Ridgepost Capital, Inc.RPC

    Quarterly report (10-Q), period ending 30 Sep 2026

    Gap Very high · 77 → Very high · 83

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    Gold.com, Inc.GOLD

    8-K · Item 2.02 — Results of operations

    Gold.com reported Q1 FY2027 earnings with $0.05 diluted EPS (vs. -$0.04 YoY), $1.6M net income, and $17.4M EBITDA. Gross margin expanded to 2.74% despite 11% revenue decline. Company declared $0.20/share dividend and highlighted acquisition synergies.

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material
  • 10-QFiled 5 Nov 2026Industrials

    Mks IncMKSI

    Quarterly report (10-Q), period ending 30 Sep 2026

    Gap Medium · 10 → High · 29

    Progress is running ahead of attention.

    More facts
    Momentum: Watch
    Material
  • 10-QFiled 5 Nov 2026All industries

    Onterris, Inc.ONT

    Quarterly report (10-Q), period ending 30 Sep 2026

    Recognition: Watch 28 → Watch 37

    More of the market is starting to notice.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    PERDOCEO EDUCATION CorpPRDO

    8-K · Item 2.02 — Results of operations

    Q3 2026 earnings per diluted share increased 16.7% YoY to $0.70; adjusted EPS grew 18.5% to $0.77. Revenue up 1.9% to $215.9M; operating income up 8.1%. Full-year 2026 EPS guidance raised to $2.93–$2.97 vs. prior $2.42.

    Recognition: Watch 37 → Watch 33Value: Strong 72 → Strong 76Gap High · 35 → Very high · 48

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Mannkind CorpMNKD

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenues grew 24% YoY to $101.9M, driven by Furoscix ReadyFlow rapid adoption (75% of shipments) and Afrezza pediatric launch success. Commercial product revenue doubled to $45M. Pipeline advanced with positive Phase 1b nintedanib DPI results.

    Gap Very high · 83 → Very high · 86

    Progress is running ahead of attention.

    More facts
    Momentum: Watch
    Material
  • 10-QFiled 5 Nov 2026All industries

    Kronos Worldwide IncKRO

    Quarterly report (10-Q), period ending 30 Sep 2026

    Gap Low · 0 → Low · 3

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Zenas BioPharma, Inc.ZBIO

    8-K · Item 2.02 — Results of operations

    Zenas reported Q3 2026 results with FDA acceptance of obexelimab BLA (PDUFA May 27, 2027), EMA MAA validation for IgG4-RD, positive Phase 3 INDIGO extension data, and $647.1M cash. Phase 2 SunStone SLE and ZB021 Phase 1 data expected Q4 2026.

    Gap Very high · 57 → Very high · 64

    Progress is running ahead of attention.

    More facts
    Momentum: Balanced
    Material
  • 10-QFiled 5 Nov 2026All industries

    Gulfport Energy CorpGPOR

    Quarterly report (10-Q), period ending 30 Sep 2026

    Gap Low · 6 → Medium · 17

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    IonQ, Inc.IONQ

    8-K · Items 2.01, 2.02, 3.02 — Acquisition or disposal of assets

    IonQ reported Q3 2026 revenue of $173.8M (336% YoY growth), sixth consecutive record quarter. Raised FY2026 guidance to $505–$515M. Backlog grew to $1.2B. Completed Elisity acquisition for quantum security. Advanced to DARPA Stage C with $300M potential value.

    News flow: Balanced 58 → Balanced 61Recognition: Balanced 56 → Strong 65Gap Very high · 88 → Very high · 91

    The filings read more positively.

    More of the market is starting to notice.

    Progress is running ahead of attention.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    ICF International, Inc.ICFI

    8-K · Items 2.02, 8.01 — Results of operations

    Recognition: Balanced 46 → Watch 40Gap High · 27 → Very high · 51

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Sarepta Therapeutics, Inc.SRPT

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenues of $323.8M in net product sales; non-GAAP operating income of $22.9M; raised full-year revenue guidance by $50M; MAD data expected Q4 2026 for DM1 and FSHD programs; $998.7M cash position supports late-stage development.

    Gap Low · 0 → Low · 8

    Progress is running ahead of attention.

    More facts
    Momentum: Watch
    Material
  • 10-QFiled 5 Nov 2026Industrials

    TransMedics Group, Inc.TMDX

    Quarterly report (10-Q), period ending 30 Sep 2026

    Recognition: Balanced 54 → Strong 67Gap Medium · 12 → Medium · 17

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 10-QFiled 5 Nov 2026Software / SaaS

    IonQ, Inc.IONQ

    Quarterly report (10-Q), period ending 30 Sep 2026

    News flow: Balanced 58 → Balanced 61Recognition: Balanced 56 → Strong 65Gap Very high · 88 → Very high · 91

    The filings read more positively.

    More of the market is starting to notice.

    Progress is running ahead of attention.

    More facts
    Momentum: Weak
    Material
  • 10-QFiled 5 Nov 2026Biotech

    Intellia Therapeutics, Inc.NTLA

    Quarterly report (10-Q), period ending 30 Sep 2026

    Gap Very high · 58 → Very high · 63

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 10-QFiled 5 Nov 2026Biotech

    Enliven Therapeutics, Inc.ELVN

    Quarterly report (10-Q), period ending 30 Sep 2026

    Recognition: Balanced 57 → Balanced 60Gap Medium · 21 → High · 27

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 10-QFiled 5 Nov 2026Software / SaaS

    First Advantage CorpFA

    Quarterly report (10-Q), period ending 30 Sep 2026

    Gap High · 25 → High · 35

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 10-QFiled 5 Nov 2026All industries

    HCI Group, Inc.HCI

    Quarterly report (10-Q), period ending 30 Sep 2026

    Value: Watch 37 → Watch 41Gap Medium · 12 → Medium · 20

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    American Healthcare REIT, Inc.AHR

    8-K · Item 2.02 — Results of operations

    AHR reported Q3 2026 results with strong Same-Store NOI growth (13.8% total portfolio, 28.2% SHOP, 15.7% ISHC). Company raised full-year 2026 guidance for NFFO per share ($2.23–$2.26) and Same-Store NOI growth (12.0%–14.0%). Acquired $1.69B in new SHOP assets; improved leverage to 1.9x Net Debt-to-Annualized Adjusted EBITDA.

    Recognition: Strong 77 → Very strong 80Gap Medium · 13 → Medium · 16

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 10-QFiled 5 Nov 2026Biotech

    Janux Therapeutics, Inc.JANX

    Quarterly report (10-Q), period ending 30 Sep 2026

    Recognition: Balanced 52 → Balanced 48Value: Balanced 57 → Balanced 51Gap Medium · 10 → Medium · 22

    Market attention has faded.

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Cogent Biosciences, Inc.COGT

    8-K · Item 2.02 — Results of operations

    Cogent reports Q3 2026 results with three imminent FDA PDUFA action dates for bezuclastinib (GIST Nov 30, NonAdvSM Dec 30, AdvSM Jun 29, 2027). Cash position of $791.1M funds operations into late 2028. Commercial team in place; pipeline expansion ongoing.

    Gap High · 36 → High · 33

    The gap narrowed — attention is catching up.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Tectonic Therapeutic, Inc.TECX

    8-K · Item 2.01 — Acquisition or disposal of assets

    Tectonic reported favorable Phase 1a safety/tolerability/PK results for TX2100, FDA Fast Track designation for HHT, IND clearance for Phase 1b, first patient dosed in ALPINE Phase 2a for TX45 in PH-ILD, and strong cash position ($234.7M) extending runway to Q1 2029.

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Gyre Therapeutics, Inc.GYRE

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue $32.9M (flat YoY); net loss $2.5M vs. prior profit. FY2026 guidance affirmed at $100.5–$111.0M. F351 NDA under NMPA review; multiple pipeline programs advancing toward clinical initiation in 2027.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 10-QFiled 5 Nov 2026All industries

    Comstock Resources IncCRK

    Quarterly report (10-Q), period ending 30 Sep 2026

    Recognition: Watch 27 → Watch 33

    More of the market is starting to notice.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026All industries

    Cvr Energy IncCVI

    8-K · Item 1.01 — Material agreement

    CVR Energy completed a $490M equity offering to fund the acquisition of St. Paul Park and Mandan refineries from Marathon Petroleum, plus debt redemption. Offering closed November 5, 2026 at $47.55/share.

    News flow: Balanced 48 → Balanced 56Gap Low · 0 → Very high · 72

    The filings read more positively.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Lexicon Pharmaceuticals, Inc.LXRX

    8-K · Item 2.02 — Results of operations

    Lexicon completed enrollment in Phase 3 SONATA-HCM trial (542 patients, exceeding target) with top-line data expected Q1 2027. STENO1 safety data supports ZYNQUISTA NDA resubmission planned Q1 2027. LX9851 Phase 1 ongoing; Lexicon earned $75M of $1B potential milestones from Novo collaboration.

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Industrials

    Kratos Defense & Security Solutions, Inc.KTOS

    8-K · Item 2.02 — Results of operations

    Kratos reported Q3 2026 revenues of $471.8M (35.7% growth, 23.2% organic), bookings of $1.037B (2.2:1 book-to-bill), record backlog of $2.65B, and Adjusted EBITDA of $50.9M (10.8% margin). Raised FY2026 guidance and provided FY2027 forecast of $2.1–$2.2B revenue and $230–$240M Adjusted EBITDA.

    Value: Watch 36 → Watch 40Gap High · 39 → Very high · 51

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material
  • 10-QFiled 5 Nov 2026All industries

    International Seaways, Inc.INSW

    Quarterly report (10-Q), period ending 30 Sep 2026

    News flow: Balanced 55 → Balanced 59Recognition: Strong 72 → Strong 68Gap Very high · 53 → Very high · 82

    The filings read more positively.

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    Netscout Systems IncNTCT

    8-K · Item 2.02 — Results of operations

    NetScout reported Q2 FY2027 revenue of $222.2M (+1.4% YoY), with operating margin expansion and reaffirmed full-year guidance of $885–$915M revenue. Service revenue grew 6.4%; product backlog declined. Company repurchased $77M in stock.

    Recognition: Watch 39 → Watch 31Value: Balanced 56 → Balanced 62Gap Low · 5 → Medium · 20

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 10-QFiled 5 Nov 2026Software / SaaS

    Netscout Systems IncNTCT

    Quarterly report (10-Q), period ending 30 Sep 2026

    Recognition: Watch 39 → Watch 31Value: Balanced 56 → Balanced 62Gap Low · 5 → Medium · 20

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Starling Oncology, Inc.STLN

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue grew 24.3% YoY to $169.8M; gross profit surged 62.1%. Adjusted EBITDA turned positive at $3.4M (vs. $(3.5)M prior year), exceeding Q3 guidance. Company affirmed full-year 2026 guidance with improved Adjusted EBITDA range ($4–6M vs. $2–7M prior).

    Recognition: Watch 43 → Watch 32

    Market attention has faded.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 10-QFiled 5 Nov 2026Industrials

    Lemaitre Vascular IncLMAT

    Quarterly report (10-Q), period ending 30 Sep 2026

    Recognition: Balanced 53 → Balanced 50Gap Low · 4 → Medium · 15

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Akamai Technologies IncAKAM

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue $1.122B (+6% YoY), driven by Cloud Infrastructure Services +34% YoY. Company projects 2027 revenue growth of 17–22% YoY and 2028 revenue exceeding $7.0B, supported by $14B in multi-year CIS commitments signed YTD.

    Value: Balanced 51 → Watch 26Gap Very high · 57 → Very high · 62

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    More facts
    Momentum: Watch
    Material
  • 10-QFiled 5 Nov 2026All industries

    Celsius Holdings, Inc.CELH

    Quarterly report (10-Q), period ending 30 Sep 2026

    Gap Very high · 76 → Very high · 80

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Industrials

    Enovis CORPENOV

    8-K · Item 2.02 — Results of operations

    Q3 2026: 5% organic sales growth, Reconstructive segment +6%, adjusted EBITDA and EPS guidance raised. Board approved $200M share repurchase authorization. Company executing innovation strategy despite market headwinds.

    Recognition: Balanced 61 → Strong 70Gap Low · 0 → Low · 7

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    Tejon Ranch CoTRC

    8-K · Item 2.02 — Results of operations

    Q3 2026 net income increased 94% to $3.3M ($0.12/share) vs. $1.7M prior year. Revenues rose 70% to $25.0M. Adjusted EBITDA grew 96% to $10.4M. Corporate expenses fell 39.8%. All segments showed improvement.

    Gap Low · 4 → Medium · 13

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026Industrials

    Lsi Industries IncLYTS

    8-K · Item 2.02 — Results of operations

    LSI reported Q1 FY2027 net sales of $225.9M (+44% YoY), adjusted net income of $11.6M (+$0.31 EPS), and free cash flow of $13.8M. Organic sales declined 2% excluding Royston acquisition. Key wins include 2,500-site refueling refresh and 3,000-store QSR renovation program.

    Gap Very high · 77 → Very high · 83

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material
  • 10-QFiled 5 Nov 2026Biotech

    Palvella Therapeutics, Inc.PVLA

    Quarterly report (10-Q), period ending 30 Sep 2026

    Recognition: Balanced 49 → Balanced 53Gap High · 34 → High · 39

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Pulse Biosciences, Inc.PLSE

    8-K · Item 2.02 — Results of operations

    Pulse Biosciences completed enrollment of NANOPULSE-AF pivotal study three months ahead of schedule with 169 patients. Company raised $95.8M in Q3 via ATM, ending quarter with $189.2M cash. Vybrance revenue grew to $0.4M; PRECISE-BTN study fully enrolled.

    No notable change in AIR's read.

    More facts
    Momentum: Very strong
    Material
  • 10-QFiled 5 Nov 2026Semiconductors

    Applied Optoelectronics, Inc.AAOI

    Quarterly report (10-Q), period ending 30 Sep 2026

    Recognition: Balanced 54 → Balanced 51Value: Watch 40 → Balanced 48Gap Very high · 58 → Very high · 66

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    More facts
    Momentum: Watch
    Material
  • 10-QFiled 5 Nov 2026Biotech

    Iovance Biotherapeutics, Inc.IOVA

    Quarterly report (10-Q), period ending 30 Sep 2026

    Value: Balanced 61 → Balanced 64Gap Medium · 14 → Medium · 19

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    Pdf Solutions IncPDFS

    8-K · Item 2.02 — Results of operations

    PDF Solutions reported Q3 2026 record revenues of $68.3M (+20% YoY), with GAAP gross margin of 73% and operating margin of 12%. GAAP diluted EPS of $0.16 vs. $0.03 prior year. Company reaffirmed 20% annual revenue growth target for 2026.

    Recognition: Balanced 54 → Balanced 51Value: Watch 29 → Watch 33

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Industrials

    Tandem Diabetes Care IncTNDM

    8-K · Item 2.02 — Results of operations

    Q3 2026 sales grew 14% YoY to $283.7M; gross margin expanded 270bps to 57%; operating loss improved 830bps to -1% of sales. Adjusted EBITDA reached $18.0M (6% margin) vs. $2.8M prior year. Pharmacy channel now 15% of U.S. sales; international expansion accelerating.

    Gap Low · 5 → Medium · 15

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 10-QFiled 5 Nov 2026Industrials

    Tandem Diabetes Care IncTNDM

    Quarterly report (10-Q), period ending 30 Sep 2026

    Gap Low · 5 → Medium · 15

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    Appian CorpAPPN

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue grew 25% YoY to $234.6M; cloud subscriptions revenue up 20% to $136.4M. GAAP net income $12.3M vs $7.8M prior year. Full-year 2026 guidance raised with cloud subscriptions expected at $536–$538M (23% growth).

    Gap Low · 3 → Medium · 10

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 10-QFiled 5 Nov 2026Software / SaaS

    Appian CorpAPPN

    Quarterly report (10-Q), period ending 30 Sep 2026

    Gap Low · 3 → Medium · 10

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 10-QFiled 5 Nov 2026Semiconductors

    SITIME CorpSITM

    Quarterly report (10-Q), period ending 30 Sep 2026

    Gap Very high · 75 → Very high · 79

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    Alarm.com Holdings, Inc.ALRM

    8-K · Item 2.02 — Results of operations

    Q3 2026 SaaS revenue grew 9.0% to $191.2M; GAAP net income $34.3M; non-GAAP adjusted EBITDA $66.2M (+19.2% YoY). Company raised full-year 2026 SaaS guidance by $12.2M midpoint and increased adjusted EBITDA outlook. CellGate acquisition and new AI video features announced.

    Value: Watch 38 → Watch 42Gap Low · 4 → Medium · 15

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 10-QFiled 5 Nov 2026Industrials

    Warby Parker Inc.WRBY

    Quarterly report (10-Q), period ending 30 Sep 2026

    Recognition: Balanced 60 → Strong 71Gap Medium · 10 → Medium · 13

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026All industries

    HA Sustainable Infrastructure Capital, Inc.HASI

    8-K · Item 2.02 — Results of operations

    HASI reported Q3 2026 Adjusted EPS of $0.82 vs. $0.80 YoY, with YTD Adjusted EPS growth of 15%. Adjusted Recurring Net Investment Income grew 15% YoY to $121M. Managed Assets reached $19.0B (+27% YoY). New investment yields exceed 11%. Reaffirmed 2028 guidance.

    No notable change in AIR's read.

    More facts
    Momentum: Strong
    Material
  • 10-QFiled 5 Nov 2026All industries

    SiriusPoint LtdSPNT

    Quarterly report (10-Q), period ending 30 Sep 2026

    Recognition: Balanced 61 → Balanced 64Gap Low · 0 → Medium · 16

    More of the market is starting to notice.

    Progress is running ahead of attention.

    More facts
    Momentum: Very strong
    Material
  • 10-QFiled 5 Nov 2026All industries

    Corvel CorpCRVL

    Quarterly report (10-Q), period ending 30 Sep 2026

    Value: Weak 17 → Weak 22Gap Low · 3 → Medium · 12

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026All industries

    SiriusPoint LtdSPNT

    8-K · Items 2.02, 8.01 — Results of operations

    Q3 2026 net income of $87M ($0.74 EPS) with 19% operating EPS growth. Core combined ratio 90.1%, ROE 15.4%. Loss portfolio transfer with RiverStone expected to unlock $200M+ capital from run-off reserves.

    Recognition: Balanced 61 → Balanced 64Gap Low · 0 → Medium · 16

    More of the market is starting to notice.

    Progress is running ahead of attention.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    Paylocity Holding CorpPCTY

    8-K · Item 2.02 — Results of operations

    Q1 FY2027 recurring revenue grew 12.0% YoY to $424.5M; total revenue up 10.7% to $451.7M. Net income $57.6M ($1.07/share) vs. $48.0M ($0.86/share) prior year. Company raised full-year FY2027 guidance. Aidora acquisition completed; $152.5M share repurchase executed.

    Gap Low · 4 → Medium · 13

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 10-QFiled 5 Nov 2026All industries

    Dorian LPG Ltd.LPG

    Quarterly report (10-Q), period ending 30 Sep 2026

    Recognition: Strong 67 → Balanced 64

    Market attention has faded.

    The price trend weakened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026All industries

    Dorian LPG Ltd.LPG

    8-K · Item 2.02 — Results of operations

    Dorian LPG reported Q2 FY2027 net income of $213.9M ($4.98 EPS), up 286% YoY, driven by elevated TCE rates ($96,990/day, +80.5% YoY), vessel sales gains ($63.6M), and strong revenues ($221.3M, +78.4% YoY). Declared $1.25/share dividend.

    Recognition: Strong 67 → Balanced 64

    Market attention has faded.

    The price trend weakened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026All industries

    Advanced Drainage Systems, Inc.WMS

    8-K · Items 2.02, 8.01 — Results of operations

    Q2 FY2027: Net sales +4.6% to $889.4M; Adjusted EBITDA $286.8M (32.2% margin). YTD organic sales +2.3%, Adjusted EBITDA +14.0%. Announced StormTrap acquisition. Dividend increased to $0.20/share. Guidance updated; demand softer than expected.

    Gap Very high · 58 → Very high · 71

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 10-QFiled 5 Nov 2026Software / SaaS

    Procore Technologies, Inc.PCOR

    Quarterly report (10-Q), period ending 30 Sep 2026

    Recognition: Strong 71 → Very strong 83Gap High · 37 → High · 25

    The gap narrowed — attention is catching up.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    Nerdwallet, Inc.NRDS

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue grew 11% YoY to $239.6M, but operating income fell 44% YoY to $19.4M and net income declined 43% YoY to $14.9M. Non-GAAP operating income and adjusted EBITDA also declined significantly YoY.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    HF Sinclair CorpDINO

    8-K · Item 1.01 — Material agreement

    HF Sinclair repurchased 2.1M shares from REH Advisors at $110.81/share (~$233M) under its $1.5B authorization. This is the 24th transaction with REH; $1B deployed to date, ~$493M remaining.

    Recognition: Strong 70 → Strong 67Value: Strong 76 → Strong 79

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    The price trend weakened.

    More facts
    Momentum: Strong
    Material
  • 10-QFiled 5 Nov 2026Semiconductors

    Power Integrations IncPOWI

    Quarterly report (10-Q), period ending 30 Sep 2026

    Value: Balanced 46 → Balanced 49Gap Low · 0 → Low · 6

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026Industrials

    Ducommun Inc /De/DCO

    8-K · Item 2.02 — Results of operations

    Ducommun reported Q3 2026 record revenue of $227.0M (+6% YoY) and record gross margin of 28.9% (+140 bps). Net income $13.9M vs. prior-year loss of $60.8M. RPO at all-time high of $1.3B; defense book-to-bill 2.2x.

    Recognition: Watch 34 → Watch 28

    Market attention has faded.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    Ingredion IncINGR

    8-K · Item 2.02 — Results of operations

    Value: Strong 79 → Very strong 82

    The shares became cheaper on AIR's value read.

    More facts
    Momentum: Weak
    Material
  • 10-QFiled 5 Nov 2026Industrials

    Ducommun Inc /De/DCO

    Quarterly report (10-Q), period ending 3 Oct 2026

    Recognition: Watch 34 → Watch 28

    Market attention has faded.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 10-QFiled 5 Nov 2026All industries

    Scansource, Inc.SCSC

    Quarterly report (10-Q), period ending 30 Sep 2026

    Fundamentals: Watch 41 → Balanced 47Recognition: Strong 70 → Balanced 61Gap Low · 6 → Low · 0

    The reported numbers improved.

    Market attention has faded.

    The gap closed as the filings read less positively.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    Americold Realty TrustCOLD

    8-K · Item 2.02 — Results of operations

    Americold reported Q3 2026 results with 4.2% YoY revenue growth, 6.0% same-store NOI growth, and maintained Adjusted FFO of $0.35/share. Company raised full-year AFFO guidance to $1.31–$1.33/share and reduced debt by $1.15B via EQT joint venture closing, improving net leverage by one turn.

    Gap High · 44 → Very high · 47

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 10-QFiled 5 Nov 2026All industries

    NCR Voyix CorpVYX

    Quarterly report (10-Q), period ending 30 Sep 2026

    Recognition: Balanced 62 → Strong 65Value: Balanced 57 → Balanced 54Gap High · 29 → High · 26

    The shares became dearer on AIR's value read.

    The gap narrowed — attention is catching up.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026Industrials

    Vontier CorpVNT

    8-K · Item 2.02 — Results of operations

    Q3 2026 results exceeded guidance with adjusted EPS of $0.92 and 12.1% adjusted operating profit growth. Company raised full-year adjusted EPS guidance to $3.60–$3.64. Core sales grew 5.7% despite 2.1% reported sales decline due to divestiture.

    Recognition: Balanced 60 → Strong 71Gap Low · 3 → Low · 9

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026All industries

    Papa Johns International IncPZZA

    8-K · Item 2.02 — Results of operations

    Q3 2026 results show significant declines: global system-wide sales down 5.6%, North America comparable sales down 8.3%, net income down 27%, adjusted EBITDA down 20%. Company lowered full-year guidance materially across key metrics.

    Value: Balanced 59 → Watch 44

    The shares became dearer on AIR's value read.

    The price trend strengthened.

    More facts
    Momentum: Weak
    Material
  • 10-QFiled 5 Nov 2026All industries

    Papa Johns International IncPZZA

    Quarterly report (10-Q), period ending 27 Sep 2026

    Value: Balanced 59 → Watch 44

    The shares became dearer on AIR's value read.

    The price trend strengthened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026Banks

    GPGI, Inc.GPGI

    8-K · Items 2.02, 8.01 — Results of operations

    GPGI lowered FY26 Adjusted EBITDA guidance by ~$45M (~8%) and Adjusted Free Cash Flow by ~$25M (~8%) due to Husky margin headwinds from delayed cost actions, freight costs, and mix, despite maintaining prior sales forecast and declaring quarterly dividend.

    Recognition: Watch 40 → Balanced 51Gap Very high · 86 → Very high · 69

    The gap narrowed — attention is catching up.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026All industries

    BKV CorpBKV

    8-K · Item 2.02 — Results of operations

    Q3 2026: BKV reported net income of $29.4M ($0.27/share), adjusted net income of $39.9M ($0.36/share), and adjusted EBITDAX of $132.7M. Key wins include cost reimbursement agreement expanding Temple modular power from 200MW to 400MW, backstop agreement with investment-grade hyperscaler for 1.2GW CCGT equipment, and Verra carbon credit certification enabling CSG monetization.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Installed Building Products, Inc.IBP

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue grew 3.9% to record $808.4M, but net income fell 20% YoY to $59.4M. Adjusted EBITDA declined 8.3% to $128.3M with margin compression from 18.0% to 15.9%, driven by residential weakness, cost inflation in fuel/aluminum, and unfavorable segment mix.

    Recognition: Watch 31 → Watch 37

    More of the market is starting to notice.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    Sabre CorpSABR

    8-K · Item 2.02 — Results of operations

    Sabre reported Q3 2026 revenue of $738M (+3% YoY), exceeded Adjusted EBITDA guidance, achieved fifth consecutive quarter of double-digit Normalized Adjusted EBITDA growth (+13% YoY to $170M), and raised full-year 2026 Pro Forma Adjusted EBITDA and Free Cash Flow guidance for the second consecutive quarter.

    Value: Very strong 83 → Strong 78

    The shares became dearer on AIR's value read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Shattuck Labs, Inc.STTK

    8-K · Item 2.02 — Results of operations

    Shattuck Labs initiated Phase 2b trial (RECEPTIVE-CD1) for SL-325 in Crohn's disease with 12-week data expected H1 2028, announced Phase 2 trial (RECEPTIVE-HS1) in hidradenitis suppurativa starting Q4 2026, and presented preclinical data for SL-846 bispecific candidate showing favorable tolerability and blockade profiles.

    Recognition: Watch 39 → Watch 36Gap Medium · 24 → High · 37

    Market attention has faded.

    Progress is running ahead of attention.

    More facts
    Momentum: Watch
    Material
  • 10-QFiled 5 Nov 2026Industrials

    Imax CorpIMAX

    Quarterly report (10-Q), period ending 30 Sep 2026

    Value: Watch 33 → Balanced 61Gap Low · 0 → Low · 8

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026All industries

    Construction Partners, Inc.ROAD

    8-K · Item 2.02 — Results of operations

    FY2026 preliminary results show ~30% revenue growth to $3.66–3.68B and ~40% net income growth to $141.5–142.5M. FY2027 outlook guides 15% growth at midpoint. Company completed acquisition of Piedmont Paving in Georgia and three additional acquisitions early in FY2027.

    Recognition: Balanced 53 → Balanced 50

    Market attention has faded.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material

Research, not tips. Filings come from SEC EDGAR; AIR's read is recomputed every trading day. A price move is shown as a fact beside a filing, never as the reason it is listed.